Development Update: U.S. FDA Grants Breakthrough Designation to CytoSorb for Removal of Ticagrelor During Cardiopulmonary Bypass in Emergent and Urgent Cardiothoracic Surgery
Stock Information for CytoSorbents Corporation
Loading
Please wait while we load your information from QuoteMedia.